Clene Reports Second Quarter 2022 Financial Results and Recent Operating Highlights
August 15, 2022 07:00 ET
|
Clene Inc.
Topline results from the Phase 2 VISIONARY-MS clinical trial with CNM-Au8® met the primary and secondary endpoints of Low Contrast Letter Acuity (LCLA) and modified Multiple Sclerosis Functional...
Pasithea Therapeutics Acquires Alpha-5 Integrin, LLC
June 22, 2022 08:00 ET
|
Pasithea
- Alpha-5 is a potentially first-in-class monoclonal antibody for the treatment of amyotrophic lateral sclerosis (ALS) and other neurological diseases -- Expands pipeline across Pasithea's core...
New Gadolinium-Free MRI Contrast Agent Advances Safer Patient Care
June 13, 2022 10:00 ET
|
Reveal Pharmaceuticals
CAMBRIDGE, Mass., June 13, 2022 (GLOBE NEWSWIRE) -- Contrast agents used in MRI scans to improve the clarity of imaging for diagnostic accuracy, accumulate in the brain and body of every patient,...
Multiple Sclerosis: Is Therapeutic Angiogenesis a Treatment or Even a Possible Cure?
November 18, 2020 00:00 ET
|
Zhittya Genesis Medicine Inc
LAS VEGAS, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (Zhittya), a private company, announced that it will give a Webinar broadcast on its potential breakthrough therapy to...
Telehealth Cognitive Rehabilitation Can Be Effective for Multiple Sclerosis
May 11, 2020 08:00 ET
|
Posit Science
SAN FRANCISCO, May 11, 2020 (GLOBE NEWSWIRE) -- An independent review of the scientific literature found that certain telehealth rehabilitation treatments can be effective in addressing cognitive...
Innodem Neurosciences reçoit un million de dollars de financement afin de donner une voix aux patients privés de la parole
February 19, 2019 15:49 ET
|
Innodem Neurosciences
MONTRÉAL, 19 févr. 2019 (GLOBE NEWSWIRE) -- Innodem Neurosciences, jeune entreprise issue de l’Institut et hôpital neurologique de Montréal (Le Neuro) de l’Université McGill et membre de...
Innodem Neurosciences Receives 1 Million Dollars in Funding to Give a Voice to Voiceless Patients
February 19, 2019 15:49 ET
|
Innodem Neurosciences
MONTREAL, Feb. 19, 2019 (GLOBE NEWSWIRE) -- CENTECH’s Innodem Neurosciences, a Montreal-based start-up that spun-out of McGill University’s Montreal Neurological Institute and Hospital (The NEURO)...
Orion Biotechnology acquires patent portfolio for potent CCR5 chemokine antagonist
September 06, 2018 13:08 ET
|
Orion Biotechnology Canada Ltd
OTTAWA, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced that its subsidiary, Orion Biotechnology Switzerland Sàrl, has...
Alectra Utilities invests $8 million in modernizing Barrie’s electricity grid
September 04, 2018 11:07 ET
|
Alectra Utilities Corporation
BARRIE, Ontario, Sept. 04, 2018 (GLOBE NEWSWIRE) -- As part of ongoing efforts to enhance overall electricity system reliability in Barrie, Alectra Utilities is investing $8 million to modernize the...
New U.S. Patent Allowance Granted to AXIM® Biotechnologies for Extraction and Purification of Delta-9-THC For Use in MedChew RX Clinical Program
June 19, 2018 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, June 19, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the United States...